MacroGenics, Inc.
MGNX
$1.31
-$0.06-4.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 255.31% | 155.26% | 16.68% | -73.10% | -73.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 255.31% | 155.26% | 16.68% | -73.10% | -73.78% |
| Cost of Revenue | 13.48% | -26.87% | -24.49% | -39.27% | -55.85% |
| Gross Profit | 214.62% | 169.49% | 420.98% | -5,669.65% | -24.29% |
| SG&A Expenses | 25.64% | 36.13% | 4.68% | -3.81% | -5.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.71% | 14.78% | 8.94% | -4.43% | -12.23% |
| Operating Income | 45.82% | 34.28% | -0.17% | -104.22% | -96.95% |
| Income Before Tax | -136.10% | -628.88% | -295.96% | -1,930.74% | 74.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -140.17% | -639.30% | -295.96% | -1,930.74% | 74.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -140.17% | -639.30% | -295.96% | -1,930.74% | 74.55% |
| EBIT | 45.82% | 34.28% | -0.17% | -104.22% | -96.95% |
| EBITDA | 47.46% | 35.03% | -3.94% | -124.03% | -115.41% |
| EPS Basic | -141.03% | -637.84% | -295.19% | -1,950.55% | 75.16% |
| Normalized Basic EPS | -293.49% | -1,024.18% | -295.21% | -1,950.95% | 75.15% |
| EPS Diluted | -132.61% | -569.44% | -298.81% | -2,105.67% | 74.10% |
| Normalized Diluted EPS | -286.91% | -975.74% | -297.07% | -2,044.10% | 74.70% |
| Average Basic Shares Outstanding | 1.19% | 1.12% | 1.02% | 0.92% | 0.80% |
| Average Diluted Shares Outstanding | 0.98% | 0.90% | 0.80% | 0.87% | 1.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |